Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by KingWhatsion Nov 10, 2010 8:01am
384 Views
Post# 17685235

RE: RE: RE: RE: RE: RE: Do I see a Cup

RE: RE: RE: RE: RE: RE: Do I see a Cup"Maybe you should stick to laundry and soap operas!" ???

Only a coward would resort to derogative statements anonymously - to a lady no less. Like irate drivers who finger little old ladies as they drive safely by.

Stock exchanges do NOT own market makers. A market maker is a brokerage firm and there are many. They trade across the financial spectrum. Institutional stockholders and individuals use them to invest in stocks and bonds. Without them there would be no market for us to play in.

Fund managers like Sprott simply call up their broker (MM) and place an order - albeit a very large order. Something like "Start buying AAPL for us. We need 10 million shares within the range of $100 +/- 2%". The broker (MM) will then start using every tool (trick) they have to acquire those shares including collaborating with other brokerage firms (MM's).

These brokerage firms will often help each other out. That is why you see those (e) signals (trades) usually between 100 and 500 shares. They might trade shares back and forth to drive the price up or down. Maybe even their own shares. Yes - they play games, but us clever little guys know all about this and govern ourselves accordingly. You can curse them all you like but that's just the way it is.

There's an axiom "If you can't beat them, join them." Learn to read the charts and profit right along with them. That's what a day trader does. If you're not a day trader you invest on the fundamentals of the company and wait - ignoring the day to day nonsense.

Yup! I'm no where near a stock broker and I admit that I only have a broad image of the inner workings of the market. I'm sure there are others here who know much more than me. If you're inclined, bring on the cowardly insults.

LOL
Bullboard Posts